PLG and type 2 diabetes mellitus: Since the tPA/plasmin system has been reported to attenuate brain amyloid deposition by cleaving Aβ [18–20], we hypothesised that it may also be effective in reducing islet amyloid deposition and its cytotoxic effects in type 2 diabetes.